{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:56:12Z","timestamp":1790362572055,"version":"4.1.0"},"reference-count":46,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005632","name":"Narodowe Centrum Bada\u0144 i Rozwoju","doi-asserted-by":"publisher","award":["V4-Korea 3\/2018"],"award-info":[{"award-number":["V4-Korea 3\/2018"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["18-01734S"],"award-info":[{"award-number":["18-01734S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Hradec Kralove, Faculty of Science","award":["VT2019-2021"],"award-info":[{"award-number":["VT2019-2021"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Poisoning with organophosphorus compounds used as pesticides or misused as chemical weapons remains a serious threat to human health and life. Their toxic effects result from irreversible blockade of the enzymes acetylcholinesterase and butyrylcholinesterase, which causes overstimulation of the cholinergic system and often leads to serious injury or death. Treatment of organophosphorus poisoning involves, among other strategies, the administration of oxime compounds. Oximes reactivate cholinesterases by breaking the covalent bond between the serine residue from the enzyme active site and the phosphorus atom of the organophosphorus compound. Although the general mechanism of reactivation has been known for years, the exact molecular aspects determining the efficiency and selectivity of individual oximes are still not clear. This hinders the development of new active compounds. In our research, using relatively simple and widely available molecular docking methods, we investigated the reactivation of acetyl- and butyrylcholinesterase blocked by sarin and tabun. For the selected oximes, their binding modes at each step of the reactivation process were identified. Amino acids essential for effective reactivation and those responsible for the selectivity of individual oximes against inhibited acetyl- and butyrylcholinesterase were identified. This research broadens the knowledge about cholinesterase reactivation and demonstrates the usefulness of molecular docking in the study of this process. The presented observations and methods can be used in the future to support the search for new effective reactivators.<\/jats:p>","DOI":"10.3390\/biom11020169","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T12:20:26Z","timestamp":1611750026000},"page":"169","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Molecular Modeling Studies on the Multistep Reactivation Process of Organophosphate-Inhibited Acetylcholinesterase and Butyrylcholinesterase"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9731-908X","authenticated-orcid":false,"given":"Jakub","family":"Jo\u0144czyk","sequence":"first","affiliation":[{"name":"Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2496-0930","authenticated-orcid":false,"given":"J\u0119drzej","family":"Kuku\u0142owicz","sequence":"additional","affiliation":[{"name":"Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"\u0141\u0105tka","sequence":"additional","affiliation":[{"name":"Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Malawska","sequence":"additional","affiliation":[{"name":"Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9492-6848","authenticated-orcid":false,"given":"Young-Sik","family":"Jung","sequence":"additional","affiliation":[{"name":"Division of Bio and Drug Discovery, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea"},{"name":"Department of Medicinal and Pharmaceutical Chemistry, University of Science and Technology, Daejeon 34113, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7504-4062","authenticated-orcid":false,"given":"Kamil","family":"Musilek","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic"},{"name":"Biomedical Research Center, University Hospital in Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6032-0354","authenticated-orcid":false,"given":"Marek","family":"Bajda","sequence":"additional","affiliation":[{"name":"Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1021\/ar2002864","article-title":"Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents","volume":"45","author":"Mercey","year":"2012","journal-title":"Acc. Chem. Res."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Gunnell, D., Eddleston, M., Phillips, M.R., and Konradsen, F. (2007). The global distribution of fatal pesticide self-poisoning: Systematic review. BMC Public Health, 7.","DOI":"10.1186\/1471-2458-7-357"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1289\/ehp.9087245","article-title":"Mechanism of action of organophosphorus and carbamate insecticides","volume":"87","author":"Fukuto","year":"1990","journal-title":"Environ. Health Perspect."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4103\/0972-5229.144017","article-title":"Clinical features of organophosphate poisoning: A review of different classification systems and approaches","volume":"18","author":"Peter","year":"2014","journal-title":"Indian J. Crit. Care Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2006.09.054","article-title":"Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning","volume":"553","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev-pharmtox-010818-021842","article-title":"Novel clinical toxicology and pharmacology of organophosphorus insecticide self-poisoning","volume":"59","author":"Eddleston","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/153476560501100205","article-title":"The Sarin Gas Attacks on the Tokyo Subway\u201410 years later\/Lessons Learned","volume":"11","author":"Beaton","year":"2005","journal-title":"Traumatology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/24734306.2018.1475151","article-title":"Novichok agents: A historical, current, and toxicological perspective","volume":"2","author":"Chai","year":"2018","journal-title":"Toxicol. Commun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11419-017-0376-7","article-title":"Fatal sarin poisoning in Syria 2013: Forensic verification within an international laboratory network","volume":"36","author":"John","year":"2018","journal-title":"Forensic Toxicol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archneur.61.5.649","article-title":"Therapy for Nerve Agent Poisoning","volume":"61","author":"Newmark","year":"2004","journal-title":"Arch. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.cbi.2005.10.052","article-title":"In vitro and in vivo characterization of recombinant human butyrylcholinesterase (ProtexiaTM) as a potential nerve agent bioscavenger","volume":"157","author":"Cerasoli","year":"2005","journal-title":"Chem. Biol. Interact."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cbi.2010.02.023","article-title":"Pseudo-catalytic scavenging: Searching for a suitable reactivator of phosphorylated butyrylcholinesterase","volume":"187","author":"Kovarik","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"9132","DOI":"10.1021\/jp502712d","article-title":"How is acetylcholinesterase phosphonylated by Soman? An ab initio QM\/MM molecular dynamics study","volume":"118","author":"Sirin","year":"2014","journal-title":"J. Phys. Chem. A"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"16011","DOI":"10.1021\/ja804941z","article-title":"Aging of cholinesterases phosphylated by tabun proceeds through O-dealkylation","volume":"130","author":"Carletti","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1042\/BJ20090091","article-title":"Structure\u2013activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun","volume":"421","author":"Carletti","year":"2009","journal-title":"Biochem. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1021\/bi0621361","article-title":"Crystal Structures of Acetylcholinesterase in Complex with Organophosphorus Compounds Suggest that the Acyl Pocket Modulates the Aging Reaction by Precluding the Formation of the Trigonal Bipyramidal Transition State","volume":"46","author":"Tunemalm","year":"2007","journal-title":"Biochemistry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.3390\/ijms14035608","article-title":"Structure-Based Search for New Inhibitors of Cholinesterases","volume":"14","author":"Bajda","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/14756360903179427","article-title":"Why acetylcholinesterase reactivators do not work in butyrylcholinesterase","volume":"25","author":"Wiesner","year":"2010","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0006-2952(03)00204-1","article-title":"Inhibition of cholinesterases with cationic phosphonyl oximes highlights distinctive properties of the charged pyridine groups of quaternary oxime reactivators","volume":"66","author":"Ashani","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1073\/pnas.1523362113","article-title":"Structure of a prereaction complex between the nerve agent sarin, its biological target acetylcholinesterase, and the antidote HI-6","volume":"113","author":"Allgardsson","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1081\/CLT-120015840","article-title":"Review of Oximes in the Antidotal Treatment of Poisoning by Organophosphorus Nerve Agents","volume":"40","author":"Kassa","year":"2002","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00204-018-2377-7","article-title":"Oxime K203: A drug candidate for the treatment of tabun intoxication","volume":"93","author":"Gorecki","year":"2019","journal-title":"Arch. Toxicol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cbi.2008.05.001","article-title":"A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats","volume":"175","author":"Kassa","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jmgm.2016.07.002","article-title":"Perspectives for the structure-based design of acetylcholinesterase reactivators","volume":"68","author":"Ochoa","year":"2016","journal-title":"J. Mol. Graph. Model."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"108735","DOI":"10.1016\/j.cbi.2019.108735","article-title":"Reactivation potency of two novel oximes (K456 and K733) against paraoxon-inhibited acetyl and butyrylcholinesterase: In silico and in vitro models","volume":"310","author":"Iqbal","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/14756366.2019.1710501","article-title":"Synthesis, in vitro screening and molecular docking of isoquinolinium-5-carbaldoximes as acetylcholinesterase and butyrylcholinesterase reactivators","volume":"35","author":"Malinak","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"10607","DOI":"10.1074\/jbc.RA119.008725","article-title":"Productive reorientation of a bound oxime reactivator revealed in room temperature X-ray structures of native and VX-inhibited human acetylcholinesterase","volume":"294","author":"Gerlits","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1039\/C5MB00735F","article-title":"The reactivation of tabun-inhibited mutant AChE with Ortho-7: Steered molecular dynamics and quantum chemical studies","volume":"12","author":"Lo","year":"2016","journal-title":"Mol. Biosyst."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1080\/14756366.2019.1609953","article-title":"Molecular modeling studies on the interactions of 7-methoxytacrine-4-pyridinealdoxime, 4-PA, 2-PAM, and obidoxime with VX-inhibited human acetylcholinesterase: A near attack conformation approach","volume":"34","author":"Nepovimova","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"108671","DOI":"10.1016\/j.cbi.2019.05.037","article-title":"Slight difference in the isomeric oximes K206 and K203 makes huge difference for the reactivation of organophosphorus-inhibited AChE: Theoretical and experimental aspects","volume":"309","author":"Polisel","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Adzhigirey","year":"2013","journal-title":"J. Comput. Aided. Mol. Des."},{"key":"ref_33","unstructured":"(2006). PyMOL, DeLano Scientific LLC. version 0.99rc6."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tox.2006.07.003","article-title":"Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase","volume":"233","author":"Bartling","year":"2007","journal-title":"Toxicology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF03033389","article-title":"In vitro reactivation potency of acetylcholinesterase reactivators\u2014K074 and K075\u2014To reactivate tabun-inhibited human brain cholinesterases","volume":"11","author":"Kuca","year":"2007","journal-title":"Neurotox. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2478\/10004-1254-60-2009-1890","article-title":"Evaluation of oxime K203 as antidote in tabun poisoning","volume":"60","author":"Kovarik","year":"2009","journal-title":"Arh. Hig. Rada Toksikol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cbi.2019.04.020","article-title":"Butyrylcholinesterase inhibited by nerve agents is efficiently reactivated with chlorinated pyridinium oximes","volume":"307","author":"Zorbaz","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tox.2006.08.012","article-title":"Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning","volume":"228","author":"Berend","year":"2006","journal-title":"Toxicology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40360-018-0196-3","article-title":"A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase","volume":"19","author":"Kuca","year":"2018","journal-title":"BMC Pharmacol. Toxicol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cbi.2010.03.053","article-title":"Aging mechanism of butyrylcholinesterase inhibited by an N-methyl analogue of tabun: Implications of the trigonal-bipyramidal transition state rearrangement for the phosphylation or reactivation of cholinesterases","volume":"187","author":"Nachon","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1021\/acs.chemrestox.8b00294","article-title":"Structural Insights of Stereospecific Inhibition of Human Acetylcholinesterase by VX and Subsequent Reactivation by HI-6","volume":"31","author":"Bester","year":"2018","journal-title":"Chem. Res. Toxicol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/prot.25073","article-title":"Structures of paraoxon-inhibited human acetylcholinesterase reveal perturbations of the acyl loop and the dimer interface","volume":"84","author":"Franklin","year":"2016","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"9937","DOI":"10.1021\/bi9905720","article-title":"Phosphoryl Oxime Inhibition of Acetylcholinesterase during Oxime Reactivation Is Prevented by Edrophonium","volume":"38","author":"Luo","year":"1999","journal-title":"Biochemistry"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"da Silva, J.A.V., Pereira, A.F., Laplante, S.R., Kuca, K., Ramalho, T.C., and Fran\u00e7a, T.C.C. (2020). Reactivation of VX-inhibited human acetylcholinesterase by deprotonated pralidoxime. A complementary quantum mechanical study. Biomolecules, 10.","DOI":"10.3390\/biom10020192"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10822-017-0036-3","article-title":"Revealing the importance of linkers in K-series oxime reactivators for tabun-inhibited AChE using quantum chemical, docking and SMD studies","volume":"31","author":"Ghosh","year":"2017","journal-title":"J. Comput. Aided. Mol. Des."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"111787","DOI":"10.1016\/j.ejmech.2019.111787","article-title":"6-Methyluracil derivatives as peripheral site ligand-hydroxamic acid conjugates: Reactivation for paraoxon-inhibited acetylcholinesterase","volume":"185","author":"Semenov","year":"2020","journal-title":"Eur. J. Med. Chem."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/11\/2\/169\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:16:11Z","timestamp":1760159771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/11\/2\/169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["biom11020169"],"URL":"https:\/\/doi.org\/10.3390\/biom11020169","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,27]]}}}